STRATEGIC PARTNERS

Enzymotec’s strategic partners are leading pharmaceutical companies and leading nutrition firms.
We’ve been fortunate to be surrounded by outstanding partners.

AAK

In 2008 Enzymotec has incorporated Advanced Lipids, a Joint Venture with AAK from Sweden. The JV is promoting products for the infant formula industry.

In 2009 Enzymotec signed a cooperation agreement with DKSH International Ltd. regarding the global supply of Enzymotec’s APIs and biofunctional products to pharma industry.

Sechang Int’l Corp.

Sechang Int’l Corp. has an agent agreement to sell Vaya Pharma products in South Korea: Vayarol™, Vayarin™, and Vayacog™.

Daiichi Sankyo, Inc.

Daiichi Sankyo, Inc. has a license agreement to sell Vayarol™ in Brazil.

Teva Pharmaceutical Industries

Teva Pharmaceutical Industries has a license agreement to sell Vaya Pharma products in Israel: Vayarol™ (Phyto-Guard), Vayarin™ (Zoom), and Vayacog™.

PFM medical singapore

PFM medical singapore has a license agreement to sell Vayarol™, in Singapore and Malaysia.